<?xml version="1.0" encoding="UTF-8"?>
<ref id="pntd.0007860.ref015">
 <label>15</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Domachowske</surname>
   <given-names>JB</given-names>
  </name>, 
  <name>
   <surname>Khan</surname>
   <given-names>AA</given-names>
  </name>, 
  <name>
   <surname>Esser</surname>
   <given-names>MT</given-names>
  </name>, 
  <name>
   <surname>Jensen</surname>
   <given-names>K</given-names>
  </name>, 
  <name>
   <surname>Takas</surname>
   <given-names>T</given-names>
  </name>, 
  <name>
   <surname>Villafana</surname>
   <given-names>T</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Safety, Tolerability and Pharmacokinetics of MEDI8897, an Extended Half-life Single-dose Respiratory Syncytial Virus Prefusion F-targeting Monoclonal Antibody Administered as a Single Dose to Healthy Preterm Infants</article-title>. 
  <source>The Pediatric infectious disease journal</source>. 
  <year>2018</year>;
  <volume>37</volume>(
  <issue>9</issue>):
  <fpage>886</fpage>â€“
  <lpage>92</lpage>. 
  <pub-id pub-id-type="doi">10.1097/INF.0000000000001916</pub-id>
  <?supplied-pmid 29373476?>
  <pub-id pub-id-type="pmid">29373476</pub-id>
 </mixed-citation>
</ref>
